The European Biotech Week celebrates biotechnology, an innovative and vibrant sector launched by the 1953 discovery of the DNA molecule. Indeed, the first edition of the Biotech Week will mark the 60th anniversary of that pivotal moment in history.
Despite having lower expectations for the future, the biotechnology sector regards its current situation as better than last year. German companies’ willingness to invest is increasingly significantly. However, companies are planning lower investments in human resources than they did last year.
We are pleased to welcome GeneQuine Biotherapeutics as a new member of BIO Deutschland.
CEOs, managing directors and HR officers from the researching health sector and life sciences industry met at BIO Deutschland’s first Human Resources Conference in Frankfurt on 23 January 2013. The motto of the event was “leadership and responsibility”. Over 90 participants attended the event, where they discussed the criteria of successful personnel management and the parameters that can be used to measure these criteria.
On 22 January 2013, representatives of BIO Deutschland attended the annual assembly of the Health Made in Germany export initiative set up by Germany Trade and Invest (GTAI). The meeting took place at the Federal Ministry of Economics and Technology in Berlin. BIO Deutschland is a member of the export initiative’s Medical Biotechnology Working Group.
BIO Deutschland’s Working Group on Technology Transfer met at KPMG’s Mannheim office on 17 January 2013 to plan a further conference on technology transfer. This event will follow up on the successful conferences in Heidelberg and Leipzig that took place some time ago.